The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127558131 12755813 1 I 20150311 20160916 20160916 EXP AU-009507513-1503AUS005971 MERCK 51.00 YR F Y 0.00000 20160916 CN AU AU

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127558131 12755813 1 PS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 UNK 20829 TABLET
127558131 12755813 2 SS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 20829 TABLET
127558131 12755813 3 SS CYCLOSPORINE. CYCLOSPORINE 1 U 0
127558131 12755813 4 SS CYCLOSPORINE. CYCLOSPORINE 1 U 0
127558131 12755813 5 SS AZATHIOPRINE. AZATHIOPRINE 1 U 0
127558131 12755813 6 SS AZATHIOPRINE. AZATHIOPRINE 1 U 0
127558131 12755813 7 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 U 0
127558131 12755813 8 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 U 0
127558131 12755813 9 SS DAPSONE. DAPSONE 1 U 0
127558131 12755813 10 SS DAPSONE. DAPSONE 1 U 0
127558131 12755813 11 SS METHOTREXATE. METHOTREXATE 1 U 0 TABLET
127558131 12755813 12 SS METHOTREXATE. METHOTREXATE 1 U 0 TABLET
127558131 12755813 13 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 U 0
127558131 12755813 14 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 U 0
127558131 12755813 15 SS PREDNISONE. PREDNISONE 1 AT A VARIABLE DOSE OF 10 TO 25 MG DAILY 0 TABLET QD
127558131 12755813 16 SS PREDNISONE. PREDNISONE 1 0 TABLET
127558131 12755813 17 C GLOBULIN, IMMUNE HUMAN IMMUNOGLOBULIN G 1 0
127558131 12755813 18 C GLOBULIN, IMMUNE HUMAN IMMUNOGLOBULIN G 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127558131 12755813 1 Urticaria
127558131 12755813 2 Angioedema
127558131 12755813 3 Urticaria
127558131 12755813 4 Angioedema
127558131 12755813 5 Urticaria
127558131 12755813 6 Angioedema
127558131 12755813 7 Urticaria
127558131 12755813 8 Angioedema
127558131 12755813 9 Urticaria
127558131 12755813 10 Angioedema
127558131 12755813 11 Angioedema
127558131 12755813 12 Urticaria
127558131 12755813 13 Urticaria
127558131 12755813 14 Angioedema
127558131 12755813 15 Urticaria
127558131 12755813 16 Angioedema
127558131 12755813 17 Urticaria
127558131 12755813 18 Angioedema

Outcome of event

Event ID CASEID OUTC COD
127558131 12755813 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127558131 12755813 Cushing's syndrome
127558131 12755813 Diabetes mellitus
127558131 12755813 Drug dependence
127558131 12755813 Hypertension
127558131 12755813 Ill-defined disorder
127558131 12755813 Off label use
127558131 12755813 Treatment failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found